Introduction
============

Schizophrenia is a complex chronic brain dysfunction that has an elusive pathogenesis and is highly heritable.[@b1-ndt-15-143] Investigations into twins and adoptees have shown that schizophrenia was caused by both genetic and environmental factors.[@b2-ndt-15-143],[@b3-ndt-15-143] Epidemiological genetic studies suggested that genetic factors contributed significantly to the etiology of schizophrenia.[@b4-ndt-15-143] Pathological mechanisms are based on various neurotransmitter and neurodevelopmental hypotheses, and the hypothesis of a 5-hydroxytryptamine (5-HT) system defect is an important one. The serotoninergic pathway has been implicated, for several reasons, as having a major role in the pathophysiology of schizophrenia. By binding with receptors, 5-HT negatively regulates cAMP-dependent signal transduction and inhibits neuronal activity by opening G-protein--gated inwardly rectifying potassium channels.[@b5-ndt-15-143] The serotonin transporter (5-HTT) has a crucial function in the regulation of 5-HT reuptake in presynaptic neurons. It has been noted that levels of 5-HTT change in schizophrenic patients.[@b6-ndt-15-143],[@b7-ndt-15-143] Significant differences in mRNA levels of the serotonin transporter gene (*SLC6A4*)[@b8-ndt-15-143] and serotonin transporter protein levels[@b9-ndt-15-143] were observed in schizophrenic patients compared with healthy controls. Pharmacological evidence indicated that 5-HTT was a site of action for several drugs with central nervous system effects[@b10-ndt-15-143],[@b11-ndt-15-143] and that 5-HTT was involved in the pathogenesis of schizophrenia.[@b12-ndt-15-143],[@b13-ndt-15-143] Therefore, the *SLC6A4* gene is a candidate gene for the pathogenesis of schizophrenia.

The most studied polymorphisms in the *SLC6A4* gene are a 44-base pair (bp) insertion--deletion (serotonin-transporter-linked polymorphic region \[5-HTTLPR\]) in the promoter region, generating major L and S alleles, and a 17-bp variable number of tandem repeats (VNTR) in the second intron (STin2).[@b14-ndt-15-143] The STin2 consists of 17-bp VNTR elements existing in 9, 10, and 12 repeats (9R, 10R, and 12R), although other rare types, such as seven-repeat units, have also been reported. The single-nucleotide polymorphisms (SNPs), rs1042173 and rs140700, are located in the three prime untranslated region and intron 5 of the *SLC6A4* gene, respectively. Associations between the *SLC6A4* gene and schizophrenia are controversial.[@b15-ndt-15-143],[@b16-ndt-15-143] Ambiguous results from different studies may possibly reflect sample sizes insufficient for obtaining adequate statistical power.

A meta-analysis is a useful method for interpreting controversial study results.[@b17-ndt-15-143],[@b18-ndt-15-143] Four meta-analyses of the association between the *SLC6A4* gene and schizophrenia have been conducted;[@b19-ndt-15-143]--[@b22-ndt-15-143] however, the results are still controversial. In addition, a meta-analysis of the association between schizophrenia and rs1042173 and rs140700 does not exist. Thus, we intended to perform an updated meta-analysis to better analyze the association of *SLC6A4* with schizophrenia.

Materials and methods
=====================

Literature searches
-------------------

To identify studies eligible for inclusion in this meta-analysis, English (PubMed and SchizophreniaGene \[SzGene\]) and Chinese language (China National Knowledge Infrastructure, Wanfang, and Weipu) databases were searched using the following keywords: "serotonin transporter," "SERTPR," "SERT-in2," "5-HTTLPR," "STin2 VNTR," "*SLC6A4*," and "schizophrenia." References of the searched articles were also reviewed to uncover more data.

Inclusion and exclusion criteria
--------------------------------

Studies included in the meta-analysis met the following criteria: 1) case--control design; 2) involved patients with schizophrenia; 3) presented relevant data for case and control groups (eg, allele/genotype frequencies, sample size, ethnicity, schizophrenia diagnostic criteria, and control group source); 4) removed duplicate sample data; and 5) published before September 2018. If the article did not contain detailed data, we e-mailed the authors for further information. Studies were excluded for the following reasons: 1) family-based studies; 2) no control group; 3) no usable genotype frequency data (attempts were made to contact authors via e-mail for such data); and 4) duplicate reported sample data.

Statistical analyses
--------------------

The meta-analysis was conducted using Stata Version 10.0 (Stata Corp., College Station, TX, USA). A *P*-value of Hardy--Weinberg equilibrium (*P*~HWE~) was calculated for control groups. Associations between *SLC6A4* and the risk of schizophrenia were detected under the random model.[@b23-ndt-15-143],[@b24-ndt-15-143] A suitable genetic model was selected according to the previous articles.[@b25-ndt-15-143] ORs and 95% CIs were calculated in the pooled and subgroup analyses.

The heterogeneity of studies was determined by using Cochran's chi-squared *Q*-statistic test.[@b26-ndt-15-143] The degree of heterogeneity was expressed as *I*^2^,which was divided into low (*I*^2^\<25%), medium (*I*^2^\~50%), and high (*I*^2^\>75%) heterogeneity.[@b27-ndt-15-143],[@b28-ndt-15-143] Publication bias was calculated by using Egger's test and was visualized in a funnel plot, in which the SE of the log OR of each study was plotted against its log OR. Sensitivity analysis, by removing one single study in turn, was conducted to test the impact of each study on pooled results. *P*-values of association, heterogeneity, and publication bias tests were represented by *P~z~*, *P~h~*, and *P~e~*, respectively. In this study, *P*\<0.05 was regarded as statistically significant in all statistical tests.[@b29-ndt-15-143] Statistical power was calculated by a PS program (Adobe Systems Incorporated, San Jose, CA, USA).[@b25-ndt-15-143]

Results
=======

Description of studies
----------------------

A total of 380 English and 16 Chinese published research articles were searched, and 46 articles were analyzed in this study after exclusion according to a PRISMA flow program ([Figure 1](#f1-ndt-15-143){ref-type="fig"}).[@b30-ndt-15-143] Detailed data on five articles could not be obtained after sending e-mails to the authors;[@b31-ndt-15-143]--[@b35-ndt-15-143] therefore, they were removed in the present meta-analysis. [Table 1](#t1-ndt-15-143){ref-type="table"} describes the baseline characteristics of 46 studies that were included in this meta-analysis. The studies included 35 articles about 5-HTTLPR,[@b16-ndt-15-143],[@b36-ndt-15-143]--[@b68-ndt-15-143] 17 studies about Stin2,[@b16-ndt-15-143],[@b37-ndt-15-143],[@b39-ndt-15-143]--[@b41-ndt-15-143],[@b44-ndt-15-143],[@b47-ndt-15-143],[@b53-ndt-15-143],[@b59-ndt-15-143],[@b65-ndt-15-143],[@b69-ndt-15-143]--[@b75-ndt-15-143] four articles about rs1042173,[@b40-ndt-15-143],[@b47-ndt-15-143],[@b76-ndt-15-143],[@b77-ndt-15-143] and four articles about rs140700.[@b71-ndt-15-143],[@b76-ndt-15-143],[@b78-ndt-15-143],[@b79-ndt-15-143]

### No association between 5-HTTLPR and the risk of schizophrenia

In a random model,[@b80-ndt-15-143],[@b81-ndt-15-143] the pooled and subgroup analyses of 8,752 cases and 10,610 controls were performed ([Table 2](#t2-ndt-15-143){ref-type="table"}). [Table 3](#t3-ndt-15-143){ref-type="table"} summarizes the results of the pooled analyses and [Table 4](#t4-ndt-15-143){ref-type="table"} depicts the data from the subgroup analyses. No association was found between 5-HTTLPR and the risk of schizophrenia with *P~z~*=0.054 (OR =1.085, 95% CI =0.999--1.178) with a power of 0.935 in the dominant model.[@b82-ndt-15-143] No associations were found in the subgroup analyses, except in an Indian group (*P~z~*=0.014, OR =1.749, 95% CI =1.120--2.731). No significant heterogeneity was observed in the pooled analysis (*P~h~*=0.294, *I*^2^=10.4%).

### Genotypes 10R/12R and 12R/12R of STin2 VNTR may be associated with the risk of schizophrenia

The allele frequencies of 7,284 cases and 8,544 controls were included in the pooled and subgroup analyses, under a random model ([Table 5](#t5-ndt-15-143){ref-type="table"}); 10R and 12R are common alleles; therefore, alleles (10R and 12R) and genotypes (10R/10R, 10R/12R, and 12R/12R) were analyzed for an association with the risk of schizophrenia, respectively ([Tables 3](#t3-ndt-15-143){ref-type="table"} and [4](#t4-ndt-15-143){ref-type="table"}). A 10R/12R genotype was a protective factor against schizophrenia (*P~z~*=0.020, OR =0.789, 95% CI =0.646--0.963), but a 12R/12R genotype was a risk factor for schizophrenia (*P~z~*=0.004, OR =1.936, 95% CI =1.238--3.029) in the pooled analyses. The two pooled analyses had high powers of 1.000. In the subgroup analyses, 10R/12R was a protective factor against schizophrenia in East Asia (*P~z~*=0.040, OR =0.617, 95% CI =0.389--0.978), India (*P~z~*=0.014, OR =0.635, 95% CI =0.441--0.913) and in a population-based analysis (*P~z~*=0.028, OR =0.794, 95% CI =0.646--0.976). A 12R/12R genotype was a risk factor for schizophrenia in East Asia (*P~z~*=0.000, OR =4.482, 95% CI =2.312--8.689) and in population-based (*P~z~*=0.013, OR =1.755, 95% CI =1.124--2.742) and hospital-based (*P~z~*=0.000, OR =10.689, 95% CI =5.303--21.544) subgroup analyses. The significant heterogeneity was observed in these associated analyses.

### Genotype GG of rs1042173 may be a risk factor for schizophrenia in Caucasians

In a recessive and a random model, no association was detected among 1,351 cases and 2,101 controls (*P~z~*=0.057, OR =1.199, 95% CI =0.994--1.445; [Table 6](#t6-ndt-15-143){ref-type="table"}). [Tables 3](#t3-ndt-15-143){ref-type="table"} and [4](#t4-ndt-15-143){ref-type="table"} shows the results. In Caucasians, a GG genotype may be a risk factor for schizophrenia (*P~z~*=0.006, OR =1.299, 95% CI =1.079--1.565), with a power of 0.893. No significant heterogeneity was observed in the pooled or subgroup analyses.

### No association between rs140700 and the risk of schizophrenia

Under a random model, the allele frequencies of 1,770 cases and 2,386 controls were included in the pooled and subgroup analyses ([Table 7](#t7-ndt-15-143){ref-type="table"}). In a dominant model, no association was detected between rs140700 and the risk of schizophrenia in the pooled and subgroup analyses ([Tables 3](#t3-ndt-15-143){ref-type="table"} and [4](#t4-ndt-15-143){ref-type="table"}). Significant heterogeneity was observed in the pooled (*P~h~*=0.000, *I*^2^=93.2%) and East Asia subgroup (*P~h~*=0.000, *I*^2^=93.5%) analyses.

### Sensitivity analysis

We conducted sensitivity analyses by omitting each study individually; the pooled ORs did not change significantly. Thus, the results were considered stable and reasonable.

### Publication bias

Any publication bias was made visible by funnel plots, in which the SE of the log OR of each study was plotted against its log OR. No evidence of publication bias was found in the pooled analyses ([Figures 2](#f2-ndt-15-143){ref-type="fig"}[](#f3-ndt-15-143){ref-type="fig"}[](#f4-ndt-15-143){ref-type="fig"}[](#f5-ndt-15-143){ref-type="fig"}[](#f6-ndt-15-143){ref-type="fig"}--[7](#f7-ndt-15-143){ref-type="fig"}).

Discussion
==========

We found no association between 5-HTTLPR and the risk of schizophrenia, except in Indians. The scale for Indians was small and was found in only one article; therefore, the association may be a false-positive. A negative association between 5-HTTLPR and the risk of schizophrenia was consistent with the results of the previous meta-analyses,[@b19-ndt-15-143],[@b21-ndt-15-143] but inconsistent with the results of Allen et al.[@b22-ndt-15-143] Differences may exist in results found because Allen et al only analyzed articles on the SzGene in their meta-analysis. An association between suicidal behavior and 5-HTTLPR was not detected in a recent meta-analysis,[@b83-ndt-15-143] which conflicts with previous evidence suggesting an association between 5-HTTLPR and violent suicidal behavior. The L allele of the 5-HTTLPR was reported as improving transcription of the *SLC6A4* gene.[@b84-ndt-15-143] A meta-analysis noted an association between the S allele of 5-HTTLPR and the risk of bipolar disorder.[@b85-ndt-15-143] Psychiatric disorders share genetic variants.[@b21-ndt-15-143] A haplotype, including 5-HTTLPR and rs16965628 markers, is thought to be associated with an obsessive--compulsive disorder.[@b86-ndt-15-143] Therefore, 5-HTTLPR may link with other SNPs to influence the serotoninergic pathway.

STin2 VNTR was associated with the risk of schizophrenia, but a significant difference was not detected in the allele analysis, inconsistent with other meta-analyses.[@b19-ndt-15-143],[@b20-ndt-15-143] Gatt et al reviewed the relevant meta-analysis between STin2 VNTR and schizophrenia and found that the 12R genotype was associated with schizophrenia as a protective factor, while 9R and 10R genotypes were not associated with schizophrenia.[@b21-ndt-15-143] Our results showed that the 10R/12R genotype was a protective factor for schizophrenia, while the 12R/12R genotype was a risk factor for schizophrenia, in the pooled and several subgroup analyses. Genotypes with 12R may significantly increase relative *5-HTT* gene expression,[@b87-ndt-15-143] leading to increasing vulnerability to schizophrenia. STin2.12R has a superior enhancer-like property within the developing rostral hindbrain, which may lead to aberrant serotonergic neuronal development.[@b40-ndt-15-143],[@b88-ndt-15-143] In addition, STin2 acts as a transcriptional regulator in an allele-dependent manner in the developing mouse brain.[@b89-ndt-15-143] Haplotype analysis demonstrated that two STin2-containing haplotypes were associated with the risk of schizophrenia, but no association was found in the single locus.[@b71-ndt-15-143] No association was detected in Caucasians and Indians, which may be the result of different genetic backgrounds. Significant heterogeneity was assessed in the pooled analysis, and heterogeneity was found in all subgroups, except Caucasians. This was the first meta-analysis of the association between the risk of schizophrenia and rs1042173 and rs140700.

Gatt et al comprehensively reviewed a meta-analysis of the association between *SLC6A4* (5-HTTLPR and STin2 VNTR) and schizophrenia.[@b21-ndt-15-143] To some extent, it would seem that our meta-analysis is superfluous. However, it was an updated analysis, assessing the association of the *SLC6A4* gene with schizophrenia using high statistical powers. Our study also included seven studies published after 2013 and three studies in Chinese. Moreover, four variations (5-HTTLPR, STin2 VNTR, rs1042173, and rs140700) were analyzed in our meta-analysis. Genome-wide association studies (GWASs) can discover novel and unexpected candidate loci in an unbiased manner. Previous GWAS analyses found that the *SLC6A4* gene was not associated with schizophrenia.[@b90-ndt-15-143]--[@b93-ndt-15-143] A comparison of 12 single-disorder GWAS meta-analyses suggested no overlap in significant genetic variants identified from the different studies.[@b21-ndt-15-143] However, structural magnetic resonance imaging scans suggested that *SLC6A4* was related to deficits of brain structural networks in schizophrenia.[@b94-ndt-15-143] Our results are inconsistent with those of the previous meta-analysis. Several reasons for this may exist: First, many recently published studies were included in our analysis; therefore, the scale of samples used was larger than those used before. Second, the articles from both English and Chinese language databases were included. Third, geographical environment, culture, lifestyle, and genetic background and diseases may affect genetic polymorphisms.[@b95-ndt-15-143],[@b96-ndt-15-143]

Significant heterogeneity was found in overall and subgroup analyses, especially for STin2 VNTR and rs140700. Although we performed subgroup analyses according to ethnicity to investigate potential sources of heterogeneity, this did not completely account for the heterogeneity. These results suggest that other aspects may partially contribute to heterogeneity, such as distinct genetic backgrounds and the different habits and customs of the people sampled.[@b97-ndt-15-143]

Overall, however, the results described herein should be interpreted with caution. First, the small sample size for rs1042173 and rs140700 should be borne in mind. Several associations only appeared in the subgroup analyses, for which only one or two articles were used. Therefore, these samples may not be representative and comprehensive. In addition, it was hard to conduct subgroup analyses for some SNPs because of so few articles. Second, deviations in the *P*~HWE~ and significant heterogeneity were observed in this study because of sample bias. Third, family-based studies, which were more robust than case--control designs, were not included in this analysis.[@b98-ndt-15-143]--[@b101-ndt-15-143] Fourth, interactions between multiple genes and SNPs may affect the risk of schizophrenia,[@b21-ndt-15-143] meaning that genetic interactional and functional studies are needed.

Conclusion
==========

Our meta-analysis showed a lack of association between 5-HTTLPR and the risk of schizophrenia, except in an Indian subgroup analysis. The 10R/12R genotype was a protective factor against schizophrenia, while the12R/12R genotype was a risk factor for schizophrenia in the pooled analyses. In Caucasians, the GG genotype of rs1042173 may be a risk factor for schizophrenia. No association was found between rs140700 and the risk of schizophrenia. Increased genetic interactional and functional studies are warranted to explore the association between polymorphisms of the *SLC6A4* gene and schizophrenia risk.
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![Funnel plot analysis on the detection of publication bias in the association between rs1042173 (GG vs GT + TT) and schizophrenia.](ndt-15-143Fig6){#f6-ndt-15-143}

![Funnel plot analysis on the detection of publication bias in the association between rs140700 (AA + AG vs GG) and schizophrenia.](ndt-15-143Fig7){#f7-ndt-15-143}

###### 

Characteristics of the qualified studies in this meta-analysis

  Authors                                     Year   Country                      Ethnicity          Controls source    Mean age of the control group   Cases, n   Controls, n   Diagnostic criteria   Gender index (case)   Gender index (control)
  ------------------------------------------- ------ ---------------------------- ------------------ ------------------ ------------------------------- ---------- ------------- --------------------- --------------------- ------------------------
                                                                                                                                                                                                                             
  Li and Li[@b65-ndt-15-143]                  2013   People's Republic of China   Han                Population-based   27.7±8.0                        526        528           *DSM-IV*              1.000                 1.000
  Frtdtrique et al[@b69-ndt-15-143]           1997   France                       Caucasians         Population-based   --                              105        114           *DSM-III-R*           0.438                 0.932
  Pae et al[@b36-ndt-15-143]                  2005   Korea                        Korea              Hospital-based     --                              111        172           *DSM-IV*              1.090                 0.000
  Saiz et al[@b37-ndt-15-143]                 2007   Spain                        Caucasians         Population-based   40.6±11.3                       227        420           *DSM-IV*              0.667                 0.961
  Naylor et al[@b38-ndt-15-143]               1998   Australia                    Caucasians         Population-based   --                              58         62            *DSM-III-R*           --                    --
  Liu et al[@b70-ndt-15-143]                  1999   People's Republic of China   Han                Population-based   42.0±10.0                       260        362           *DSM-III-R*           0.709                 0.813
  Ikeda et al[@b39-ndt-15-143]                2006   Japan                        Japanese           Population-based   33.6±12.9                       287        288           *DSM-IV*              0.939                 0.92
  Lin et al[@b71-ndt-15-143]                  2009   People's Republic of China   Han                Population-based   37.0±8.16                       329        288           *DSM-IV*              0.621                 0.811
  Vijayan et al[@b40-ndt-15-143]              2009   Indian                       Indian             Population-based   31.7±6.92                       243        243           *DSM-IV*              --                    --
  Lee et al[@b41-ndt-15-143]                  2009   Korea                        Korea              Population-based   --                              141        115           *DSM-IV*              --                    --
  Pae et al[@b42-ndt-15-143]                  2003   Korea                        Korea              Hospital-based     30.3±9.4                        111        208           *DSM-IV*              1.096                 0.818
  Gu et al[@b43-ndt-15-143]                   2013   People's Republic of China   Han                Population-based   22.4±6.6                        404        385           ICD-10                0.515                 0.629
  Kaiser et al[@b16-ndt-15-143]               2001   Germany                      Caucasians         Population-based   30.1±7.6                        684        587           *DSM-IV*              0.887                 0.289
  Tsai et al[@b72-ndt-15-143]                 2002   People's Republic of China   Han                Hospital-based     42.8±9.2                        114        127           *DSM-III-R*           1.426                 1.822
  Herken et al[@b44-ndt-15-143]               2003   Turkey                       Caucasians         Population-based   --                              143        68            *DSM-IV*              1.860                 --
  Serretti et al[@b45-ndt-15-143]             2002   Raffaele                     Caucasians         Hospital-based     46.0±15.5                       261        457           *DSM-IV*              --                    1.041
  Tsai et al[@b67-ndt-15-143]                 2000   People's Republic of China   Han                Population-based   49.6±0.8                        90         104           *DSM-IV*              0.525                 2.596
  Han et al[@b46-ndt-15-143]                  2004   Korea                        Korean             Hospital-based     --                              168        158           *DSM-IV*              --                    --
  Zaboli et al[@b47-ndt-15-143]               2008   European                     Caucasians         Population-based   41.0±11.2                       155        246           *DSM-III-R*           0.667                 0.629
  Golimbet et al[@b48-ndt-15-143]             2017   Russian                      Russian            Population-based   34.3±18.1                       1,285      1,061         ICD-10                1.633                 2.333
  Herken et al[@b73-ndt-15-143]               2002   Turkish                      Turkish            Population-based   --                              128        135           *DSM-IV*              --                    --
  Peitl et al[@b49-ndt-15-143]                2017   Croatia                      Croatia            Population-based   37.6±11.5                       300        291           *DSM-IV*              0.376                 0.865
  Carlstrom et al[@b76-ndt-15-143]            2012   Scandinavia                  Caucasians         Population-based   --                              837        1,473         *DSM-IV*              --                    --
  Terzic et al[@b50-ndt-15-143]               2015   Ljubljana                    Slovenian          Population-based   --                              138        94            *DSM-IV*              --                    --
  Lu et al[@b68-ndt-15-143]                   2012   the Netherland and Germany   Caucasians         Population-based   --                              2,030      1,288         *DSM-IV*              --                    --
  Golimbet et al[@b51-ndt-15-143]             2010   Russian                      Russian            Population-based   55.6±20.5                       58         62            ICD-10                0.277                 0.824
  Golimbet et al[@b52-ndt-15-143]             2003   Russian                      Russian            Hospital-based     31.6±13.5                       110        124           ICD-10                0.746                 1.696
  Stober et al[@b53-ndt-15-143]               1998   German                       Caucasians         population-based   29.9±10.0                       180        223           ICD-10                0.622                 0.701
  Collier et al[@b74-ndt-15-143]              1996   European                     Caucasians         Population-based   --                              129        187           *DSM-III-R*           --                    --
  Kotler et al[@b54-ndt-15-143]               1999                                                   Population-based   28.0±15.0                       82         821           ICD-10                0.586                 1.61
  Rao et al[@b55-ndt-15-143]                  1998   The USA                      Caucasians         Population-based   30.0±10.0                       80         127           *DSM-IV*              0.667                 1.953
  Rao et al[@b55-ndt-15-143]                  1998   The USA                      African American   Population-based   30.0±8.0                        47         37            *DSM-IV*              0.741                 1.313
  Pakhomova et al[@b56-ndt-15-143]            2011   Russian                      Russian            Population-based   18.9±6.7                        65         111           ICD-10                0.444                 0.609
  Mendes de Oliveira et al[@b57-ndt-15-143]   1998   European                     Caucasians         Hospital-based     --                              39         89            *DSM-IV*              --                    --
  Bayle et al[@b58-ndt-15-143]                2003   French                       Caucasians         Hospital-based     35.0±10.0                       185        159           *DSM-IV*              0.434                 0.529
  Mata et al[@b59-ndt-15-143]                 2004   Spain                        Caucasians         Population-based   26.9±5.5                        187        278           *DSM-IV*              0.680                 0.887
  Sanjuan et al[@b60-ndt-15-143]              2006   Spain                        Caucasians         Population-based   --                              158        138           *DSM-IV*              0.500                 --
  Pal et al[@b79-ndt-15-143]                  2009   Croatian                     Caucasians         Population-based   50.3±7.5                        104        131           ICD-10                0.705                 --
  Chong et al[@b61-ndt-15-143]                2000                                East Asia          Population-based   --                              338        103           *DSM-IV*              0.565                 --
  Pae et al[@b62-ndt-15-143]                  2006   Koreans                      Koreans            Hospital-based     --                              152        152           *DSM-IV*              --                    --
  Young et al[@b63-ndt-15-143]                2006   The USA                      Caucasians         Population-based   --                              12         15            *DSM-IV*              --                    --
  Jing et al[@b64-ndt-15-143]                 2016   People's Republic of China   Han                Population-based   30.9±6.7                        624        683           *DSM-IV*              0.830                 0.882
  Li et al[@b78-ndt-15-143]                   2013   People's Republic of China   Han                Population-based   33.1±11.8                       189        300           *DSM-IV*              2.316                 2.297
  Yang et al[@b75-ndt-15-143]                 2001   People's Republic of China   Han                Population-based   --                              260        362           *DSM-III-R*           --                    --
  Zuo et al[@b66-ndt-15-143]                  2003   People's Republic of China   Han                Hospital-based     --                              157        185           CCMD-II-R             0.622                 0.312
  Xuan et al[@b77-ndt-15-143]                 2012   People's Republic of China   Han                Population-based   --                              132        150           *DSM-IV*              1.000                 1.000

**Abbreviations:** CCMD-II-R, Chinese Classification of Mental Disorders, Second Edition, Revised; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; ICD-10, International Classification of Diseases-10.

###### 

Genotype distribution and allele frequency of 5-HTTLPR

  Authors                                     Year   Genotype distribution   *P*~HWE~   Allele frequency                                                     
  ------------------------------------------- ------ ----------------------- ---------- ------------------ ----- ----- ----- ------- ------- ------- ------- -------
                                                                                                                                                             
  Pae et al[@b36-ndt-15-143]                  2005   4                       35         72                 10    49    113   0.143   43      179     69      275
  Saiz                                        2007   64                      104        59                 124   203   93    0.566   232     222     451     389
  Naylor et al[@b38-ndt-15-143]               1998   11                      30         17                 19    29    14    0.646   52      64      67      57
  Ikeda et al[@b39-ndt-15-143]                2006   16                      82         189                12    101   175   0.588   114     460     125     451
  Vijayan et al[@b40-ndt-15-143]              2009   40                      123        79                 62    118   61    0.748   203     281     242     240
  Lee et al[@b41-ndt-15-143]                  2009   7                       52         82                 3     45    67    0.151   66      216     51      179
  Pae et al[@b42-ndt-15-143]                  2003   4                       35         72                 11    58    139   0.140   43      179     80      336
  Gu et al[@b43-ndt-15-143]                   2013   14                      101        289                7     90    288   0.992   129     679     104     666
  Kaiser et al[@b16-ndt-15-143]               2001   253                     324        107                207   286   94    0.772   830     538     700     474
  Herken et al[@b44-ndt-15-143]               2003   30                      70         40                 17    24    27    0.022   130     150     58      78
  Serretti et al[@b45-ndt-15-143]             2002   89                      121        51                 165   217   75    0.800   299     223     547     367
  Tsai et al[@b67-ndt-15-143]                 1999   9                       28         53                 15    30    59    0.002   46      134     60      148
  Han et al[@b46-ndt-15-143]                  2004   7                       52         109                8     54    96    0.910   66      270     70      246
  Zaboli et al[@b47-ndt-15-143]               2008   56                      73         26                 75    126   45    0.532   185     125     276     216
  Golimbet et al[@b48-ndt-15-143]             2017   486                     595        204                413   503   145   0.677   1,567   1,003   1,329   793
  Peitl et al[@b49-ndt-15-143]                2017   118                     124        58                 103   138   50    0.746   360     240     344     238
  Terzic                                      2015   52                      71         15                 47    34    13    0.104   175     101     128     60
  Lu et al[@b68-ndt-15-143]                   2012   407                     626        254                690   992   345   0.719   1,440   1,134   2,372   1,682
  Golimbet et al[@b51-ndt-15-143]             2010   27                      20         11                 22    28    12    0.567   74      42      72      52
  Golimbet et al[@b52-ndt-15-143]             2003   42                      46         22                 45    57    22    0.594   130     90      147     101
  Stober                                      1998   58                      90         32                 79    112   42    0.834   206     154     270     196
  Kotler et al[@b54-ndt-15-143]               1999   24                      38         20                 210   446   165   0.010   86      78      866     776
  Rao et al[@b55-ndt-15-143]                  1998   28                      32         20                 43    59    25    0.559   88      72      145     109
  Rao et al[@b55-ndt-15-143]                  1998   25                      18         4                  18    12    7     0.079   68      26      48      26
  Pakhomova                                   2011   20                      37         8                  43    48    20    0.310   77      53      134     88
  Mendes de Oliveira et al[@b57-ndt-15-143]   1998   12                      21         6                  39    43    16    0.480   45      33      121     75
  Bayle et al[@b58-ndt-15-143]                2003   48                      99         38                 40    83    36    0.573   195     175     163     155
  Mata et al[@b59-ndt-15-143]                 2004   41                      102        44                 63    124   91    0.100   184     190     250     306
  Sanjuan et al[@b60-ndt-15-143]              2006   33                      78         47                 44    68    26    0.976   144     172     156     120
  Chong et al[@b61-ndt-15-143]                2000   33                      130        175                13    32    58    0.019   196     480     58      148
  Pae et al[@b62-ndt-15-143]                  2006   5                       46         101                9     47    96    0.322   56      248     65      239
  Young                                       2006   2                       5          5                  6     7     2     0.985   9       15      19      11
  Jing et al[@b64-ndt-15-143]                 2016   51                      267        306                66    248   369   0.012   369     879     380     986
  Li et al[@b78-ndt-15-143]                   2013   5                       35         149                24    134   142   0.325   45      333     182     418
  Zuo                                         2003   15                      50         92                 21    49    115   0.000   80      234     91      279

**Abbreviations:** 5-HTTLPR, serotonin-transporter-linked polymorphic region; *P*~HWE~, *P*-value of Hardy--Weinberg equilibrium.

###### 

Pooled association of *SLC6A4* polymorphisms with schizophrenia

  Loci         Genetic model             Studies (n)   Statistical   OR      95% CI         *P~z~*   *I*^2^   *P~h~*   *P~e~*
  ------------ ------------------------- ------------- ------------- ------- -------------- -------- -------- -------- --------
                                                                                                                       
  5-HTTLPR     Allele contrast           35            Random        0.934   0.868--1.004   0.066    53.6     0.000    0.587
               Homozygous codominant     35            Random        1.142   0.782--0.980   0.021    15.6     0.206    0.912
               Heterozygous codominant   35            Random        1.066   0.980--1.161   0.138    7.7      0.340    0.165
               Dominant                  35            Random        1.085   0.999--1.178   0.054    10.4     0.294    0.211
               Recessive                 35            Random        1.082   0.961--1.218   0.195    57.8     0.000    0.846
  STin2 VNTR   10R vs others             17            Random        0.884   0.725--1.077   0.221    82.8     0.000    0.951
               12R vs others             17            Random        1.134   0.931--1.381   0.21     82.8     0.000    0.936
               10R/10R vs others         17            Random        0.907   0.624--1.319   0.611    78.9     0.000    0.401
               10R/12R vs others         17            Random        0.789   0.646--0.963   0.020    71.1     0.000    0.748
               12R/12R vs others         17            Random        1.936   1.238--3.029   0.004    94.7     0.000    0.474
  rs1042173    Contrast                  4             Random        1.094   0.962--1.245   0.17     22.7     0.275    0.412
               Homozygous codominant     4             Random        1.214   0.921--1.600   0.169    26.4     0.253    0.336
               Heterozygous codominant   4             Random        1.011   0.812--1.260   0.920    18.0     0.301    0.941
               Dominant                  4             Random        1.077   0.856--1.354   0.528    26.9     0.250    0.722
               Recessive                 4             Random        1.199   0.994--1.445   0.057    14.5     0.320    0.155
  rs140700     Allele contrast           4             Random        1.052   0.519--1.734   0.863    92.9     0.000    0.359
               Homozygous codominant     4             Random        0.809   0.236--2.774   0.736    63.7     0.041    0.223
               Heterozygous codominant   4             Random        0.971   0.500--1.884   0.931    91.9     0.000    0.685
               Dominant                  4             Random        1.003   0.503--1.999   0.993    93.2     0.000    0.560
               Recessive                 4             Random        0.830   0.284--2.422   0.733    53.5     0.092    0.333

**Abbreviations:** 5-HTTLPR, serotonin-transporter-linked polymorphic region; *P~z~*, *P~h~*, and *P~e~*, *P*-values of association, heterogeneity, and publication bias tests, respectively; R, repeats; STin2 VNTR, second intron variable number of tandem repeats.

###### 

Subgroup association of *SLC6A4* polymorphisms with schizophrenia

  Loci              Subgroup analysis   Studies (n)   OR       95% CI          *P~z~*   *I*^2^   *P~h~*
  ----------------- ------------------- ------------- -------- --------------- -------- -------- --------
                                                                                                 
  5HTTLPR           Caucasians          21            1.053    0.974--1.138    0.192    1.6      0.437
                    East Asia           12            1.204    0.953--1.521    0.119    4.1      0.404
                    African American    1             0.834    0.352--1.975    0.679    0.0      0.000
                    Indians             1             1.749    1.120--2.731    0.014    0.0      0.000
                    Population-based    26            1.089    0.982--1.209    0.131    28.3     0.090
                    Hospital-based      9             1.094    0.897--1.335    0.273    0.0      0.939
  STin2 VNTR 1010   Caucasians          9             0.883    0.645--1.207    0.435    63.7     0.005
                    East Asia           7             0.857    0.310--2.374    0.767    75.5     0.00
                    Indians             1             0.639    0.368--1.108    0.111    --       0.000
                    Population-based    16            0.930    0.639--1.354    0.704    79.8     0.000
                    Hospital-based      1             0.155    0.008--3.040    0.220    --       --
  1012              Caucasians          9             0.944    0.832--1.072    0.374    0.0      0.706
                    East Asia           7             0.617    0.389--0.978    0.040    80.8     0.000
                    Indians             1             0.635    0.441--0.913    0.014    --       --
                    Population-based    16            0.794    0.646--0.976    0.028    72.8     0.000
                    Hospital-based      1             0.667    0.290--1.536    0.341    --       --
  1212              Caucasians          9             1.042    0.916--1.186    0.531    0.0      0.885
                    East Asia           7             4.482    2.312--8.689    0.000    92.1     0.000
                    Indians             1             1.573    1.086--2.280    0.170    --       --
                    Population-based    16            1.755    1.124--2.742    0.013    94.5     0.000
                    Hospital-based      1             10.689   5.303--21.544   0.000    --       --
  rs1042173         Caucasians          2             1.299    1.0791.565      0.006    0.0      0.421
                    East Asia           1             0.834    0.5171.346      0.458    --       --
                    Indians             1             1.213    0.7981.843      0.365    --       --
  rs140700          Caucasians          2             1.253    0.8271.896      0.287    42.6     0.187
                    East Asia           2             0.757    0.2152.670      0.665    93.5     0.000

**Abbreviations:** 5-HTTLPR, serotonin-transporter-linked polymorphic region; *P~z~* and *P~h~*, *P*-values of association and heterogeneity, respectively; STin2 VNTR, second intron variable number of tandem repeats.

###### 

Genotype distribution and allele frequency of STin2 VNTR

  Authors                          Year   Genotype distribution   Allele frequency                                                                  
  -------------------------------- ------ ----------------------- ------------------ ---- ----- ----- ---- ----- ----- ----- ---- ----- ----- ----- ----
                                                                                                                                                    
  Frtdtrique                       1997   84                      120                6    79    143   6    24    36    39    6    18    41    50    5
  Saiz                             2007   171                     281                2    305   530   5    42    86    97    2    64    177   174   5
  Liu et al[@b70-ndt-15-143]       1999   22                      498                0    58    665   1    2     18    240   0    5     48    308   1
  Ikeda et al[@b39-ndt-15-143]     2006   51                      523                0    46    530   0    1     49    237   0    3     40    245   0
  Lin et al[@b71-ndt-15-143]       2009   55                      425                0    107   457   0    6     43    191   0    9     89    184   0
  Vijayan et al[@b40-ndt-15-143]   2009   137                     343                0    189   297   0    24    89    127   0    36    117   90    0
  Lee et al[@b41-ndt-15-143]       2009   36                      246                0    23    207   0    4     28    109   0    3     17    95    0
  Kaiser et al[@b16-ndt-15-143]    2001   493                     835                40   485   668   21   95    291   259   39   108   259   199   21
  Tsai et al[@b72-ndt-15-143]      2002   10                      218                0    22    232   0    0     10    104   0    3     16    108   0
  Herken et al[@b44-ndt-15-143]    2003   82                      204                0    31    59    0    12    58    73    0    8     15    22    0
  Zaboli et al[@b47-ndt-15-143]    2008   122                     184                0    176   302   0    30    62    61    0    29    118   92    0
  Herken et al[@b73-ndt-15-143]    2002   72                      184                0    71    198   1    9     54    65    0    7     57    70    1
  Stober                           1998   141                     217                2    204   254   8    29    83    66    2    54    96    75    8
  Collier et al[@b74-ndt-15-143]   1996   94                      162                2    169   202   3    19    56    52    2    42    85    57    3
  Mata et al[@b59-ndt-15-143]      2004   103                     221                0    178   288   0    15    73    74    0    37    104   92    0
  Li et al[@b78-ndt-15-143]        2013   333                     45                 0    418   182   0    149   35    5     0    142   134   24    0
  Yang                             2001   22                      498                0    58    665   1    2     18    240   0    5     48    308   1

**Abbreviation:** STin2 VNTR, second intron variable number of tandem repeats.

###### 

Genotype distribution and allele frequency of rs1042173

  Authors                          Year   Genotype distribution   *P*~HWE~   Allele frequency                                                 
  -------------------------------- ------ ----------------------- ---------- ------------------ ----- ----- ----- ------- ----- ----- ------- -------
                                                                                                                                              
  Vijayan et al[@b40-ndt-15-143]   2009   63                      119        50                 55    112   67    0.538   245   219   222     246
  Zaboli et al[@b47-ndt-15-143]    2008   39                      78         38                 58    129   59    0.444   156   154   245     247
  Carlstrom                        2012   207                     402        223                291   770   410   0.039   816   848   1,352   1,590
  Xuan et al[@b77-ndt-15-143]      2012   77                      43         12                 94    48    8     0.568   197   67    236     64

**Abbreviation:** *P*~HWE~, *P*-value of Hardy--Weinberg equilibrium.

###### 

Genotype distribution and allele frequency of rs140700

  Authors                      Year   Genotype distribution   *P*~HWE~   Allele frequency                                                    
  ---------------------------- ------ ----------------------- ---------- ------------------ ------- ----- ---- ------- ------- ----- ------- -----
                                                                                                                                             
  Li et al[@b78-ndt-15-143]    2013   369                     127        30                 259     212   57   0.173   865     187   730     326
  Lin et al[@b71-ndt-15-143]   2009   277                     30         2                  244     18    1    0.295   584     34    506     20
  Carlstrom                    2012   689                     140        2                  1,233   221   10   0.977   1,518   144   2,687   241
  Pal et al[@b79-ndt-15-143]   2009   80                      19         5                  112     18    1    0.769   179     29    242     20

**Abbreviation:** *P*~HWE~, *P*-value of Hardy--Weinberg equilibrium.
